Search Results 341-350 of 18995 for crohns disease
To determine the efficacy and safety of multiple doses of ABT-494 in subjects with moderately to severely active Crohn's Disease with a history of inadequate ...
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment.
As many as 26% of people with Crohn's disease will develop perianal fistulas. Most often, it starts with an infection within the anal gland and often progresses ...
Inflammatory bowel disease — Crohn's disease and ulcerative colitis · Diverticulitis and diverticular disease; Anal problems such as hemorrhoids, fistula and ...
Incidence and prevalence of Crohn's disease and ulcerative colitis. Unusual and unforeseen complications of inflammatory bowel disease. Clinical trials of ...
Mayo Clinic's inflammatory bowel disease (IBD) serum and tissue biobank involves all Mayo Clinic campuses. Research into serological and genetic markers may ...
Inflammatory bowel disease (Crohn's disease/ulcerative colitis) · Pediatric to Adult care transition · Pediatric IBD clinical trials · Stem cell trials/research ...
A large study demonstrates an elevated risk of colorectal cancer in individuals with inflammatory bowel disease (IBD) and in individuals with IBD who have a ...
These may include Crohn's disease, inflammatory bowel disease and celiac disease. Weakened immune system. If your body's germ-fighting immune system is ...
... and chronic severe plaque psoriasis. It is used in children to treat Crohn's disease and ulcerative colitis. Infliximab-abda injection is a monoclonal ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.